keyword
https://read.qxmd.com/read/38690711/switching-from-tenofovir-disoproxil-fumarate-to-tenofovir-alafenamide-in-virologically-suppressed-patient-with-chronic-hepatitis-b
#1
JOURNAL ARTICLE
Heechul Nam, Ji Won Han, Soon Kyu Lee, Hyun Yang, Hae Lim Lee, Pil Soo Sung, Myeong Jun Song, Jung Hyun Kwon, Jeong Won Jang, U-Im Chang, Chang Wook Kim, Soon Woo Nam, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Jin Mo Yang, Hee Yeon Kim
BACKGROUND AND AIM: Our study evaluated the outcomes of switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in patients with chronic hepatitis B (CHB). We assessed viral and biochemical responses as well as changes in the estimated glomerular filtration rate (eGFR) and bone mineral density (BMD). METHODS: This retrospective multicenter study included CHB patients who achieved virologic response (VR) (HBV DNA < 20 IU/mL) while on TDF and were subsequently switched to TAF between April 2018 and October 2021...
May 1, 2024: Journal of Gastroenterology and Hepatology
https://read.qxmd.com/read/38689752/-klebsiella-pneumoniae-infections-after-liver-transplantation-drug-resistance-and-distribution-of-pathogens-risk-factors-and-influence-on-outcomes
#2
JOURNAL ARTICLE
Long Guo, Peng Peng, Wei-Ting Peng, Jie Zhao, Qi-Quan Wan
BACKGROUND: Liver transplantation (LT) is the only curative treatment for end-stage liver disease. However, LT recipients are susceptible to infection, which is the leading cause of early mortality after LT. Klebsiella pneumoniae infections (KPIs) in the bloodstream are common in LT recipients. We hypothesized that KPIs and carbapenem-resistant Klebsiella pneumoniae (CRKP) infections may affect the outcomes of LT recipients. AIM: To assess KPI incidence, timing, distribution, drug resistance, and risk factors following LT and its association with outcomes...
April 27, 2024: World Journal of Hepatology
https://read.qxmd.com/read/38689751/prospective-study-of-hepatitis-b-and-d-epidemiology-and-risk-factors-in-romania-a-10-year-update
#3
JOURNAL ARTICLE
Speranta Iacob, Liana Gheorghe, Mirela Onica, Laura Huiban, Corina Silvia Pop, Ciprian Brisc, Roxana Sirli, Carmen Ester, Cristina Mihaela Brisc, Sorina Diaconu, Ion Rogoveanu, Larisa Sandulescu, Deiana Vuletici, Anca Trifan
BACKGROUND: The global burden of hepatitis D virus (HDV) infection represents a major medical challenge and a public health crisis worldwide. However, there is a lack of accurate data on the epidemiology and risk factors for HDV. Hepatitis B virus (HBV) and HDV coinfection causes the most severe form of viral hepatitis, leading to a higher cumulative incidence of liver-related events compared with HBV monoinfection, including the need for liver transplantation and death. AIM: To investigate the epidemiology, natural history, risk factors and clinical management of HBV and HDV coinfection in Romanian patients...
April 27, 2024: World Journal of Hepatology
https://read.qxmd.com/read/38689750/development-and-validation-of-a-nomogram-for-predicting-in-hospital-mortality-of-intensive-care-unit-patients-with-liver-cirrhosis
#4
JOURNAL ARTICLE
Xiao-Wei Tang, Wen-Sen Ren, Shu Huang, Kang Zou, Huan Xu, Xiao-Min Shi, Wei Zhang, Lei Shi, Mu-Han Lü
BACKGROUND: Liver cirrhosis patients admitted to intensive care unit (ICU) have a high mortality rate. AIM: To establish and validate a nomogram for predicting in-hospital mortality of ICU patients with liver cirrhosis. METHODS: We extracted demographic, etiological, vital sign, laboratory test, comorbidity, complication, treatment, and severity score data of liver cirrhosis patients from the Medical Information Mart for Intensive Care IV (MIMIC-IV) and electronic ICU (eICU) collaborative research database (eICU-CRD)...
April 27, 2024: World Journal of Hepatology
https://read.qxmd.com/read/38689749/multifaceted-roles-of-lymphatic-and-blood-endothelial-cells-in-the-tumor-microenvironment-of-hepatocellular-carcinoma-a-comprehensive-review
#5
REVIEW
Jing-Jing Li, Jia-Xi Mao, Han-Xiang Zhong, Yuan-Yu Zhao, Fei Teng, Xin-Yi Lu, Li-Ye Zhu, Yang Gao, Hong Fu, Wen-Yuan Guo
The tumor microenvironment is a complex network of cells, extracellular matrix, and signaling molecules that plays a critical role in tumor progression and metastasis. Lymphatic and blood vessels are major routes for solid tumor metastasis and essential parts of tumor drainage conduits. However, recent studies have shown that lymphatic endothelial cells (LECs) and blood endothelial cells (BECs) also play multifaceted roles in the tumor microenvironment beyond their structural functions, particularly in hepatocellular carcinoma (HCC)...
April 27, 2024: World Journal of Hepatology
https://read.qxmd.com/read/38689748/spectrum-of-covid-19-induced-liver-injury-a-review-report
#6
REVIEW
Lokjan Singh, Anil Kumar, Maya Rai, Bibek Basnet, Nishant Rai, Pukar Khanal, Kok-Song Lai, Wan-Hee Cheng, Ahmed Morad Asaad, Shamshul Ansari
The coronavirus disease 2019 (COVID-19) pandemic has caused changes in the global health system, causing significant setbacks in healthcare systems worldwide. This pandemic has also shown resilience, flexibility, and creativity in reacting to the tragedy. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection targets most of the respiratory tract, resulting in a severe sickness called acute respiratory distress syndrome that may be fatal in some individuals. Although the lung is the primary organ targeted by COVID-19 viruses, the clinical aspect of the disease is varied and ranges from asymptomatic to respiratory failure...
April 27, 2024: World Journal of Hepatology
https://read.qxmd.com/read/38689747/relative-carcinogenicity-of-tacrolimus-vs-mycophenolate-after-solid-organ-transplantation-and-its-implications-for-liver-transplant-care
#7
JOURNAL ARTICLE
Dorothy Liu, Mark M Youssef, Josephine A Grace, Marie Sinclair
BACKGROUND: De novo malignancy is a leading cause of late morbidity and mortality in liver transplant recipients. Cumulative immunosuppression has been shown to contribute to post-transplant malignancy (PTM) risk. There is emerging evidence on the differential carcinogenic risk profile of individual immunosuppressive drugs, independent of the net effect of immunosuppression. Calcineurin inhibitors such as tacrolimus may promote tumourigenesis, whereas mycophenolic acid (MPA), the active metabolite of mycophenolate mofetil, may limit tumour progression...
April 27, 2024: World Journal of Hepatology
https://read.qxmd.com/read/38689746/subclinical-hepatitis-e-virus-genotype-1-infection-the-concept-of-dynamic-human-reservoir
#8
EDITORIAL
Ananta Shrestha, Suresh Basnet, Sudhamshu Kc
Hepatitis E virus (HEV) is hyperendemic in South Asia and Africa accounting for half of total Global HEV burden. There are eight genotypes of HEV. Among them, the four common ones known to infect humans, genotypes 1 and 2 are prevalent in the developing world and genotypes 3 and 4 are causing challenge in the industrialized world. Asymptomatic HEV viremia in the general population, especially among blood donors, has been reported in the literature worldwide. The clinical implications related to this asymptomatic viremia are unclear and need further exploration...
April 27, 2024: World Journal of Hepatology
https://read.qxmd.com/read/38689745/quantitative-hepatitis-b-core-antibody-and-quantitative-hepatitis-b-surface-antigen-novel-viral-biomarkers-for-chronic-hepatitis-b-management
#9
REVIEW
Wattana Leowattana, Pathomthep Leowattana, Tawithep Leowattana
The management of hepatitis B virus (HBV) infection now involves regular and appropriate monitoring of viral activity, disease progression, and treatment response. Traditional HBV infection biomarkers are limited in their ability to predict clinical outcomes or therapeutic effectiveness. Quantitation of HBV core antibodies (qAnti-HBc) is a novel non-invasive biomarker that may help with a variety of diagnostic issues. It was shown to correlate strongly with infection stages, hepatic inflammation and fibrosis, chronic infection exacerbations, and the presence of occult infection...
April 27, 2024: World Journal of Hepatology
https://read.qxmd.com/read/38689744/progress-of-mitochondrial-and-endoplasmic-reticulum-associated-signaling-and-its-regulation-of-chronic-liver-disease-by-chinese-medicine
#10
EDITORIAL
Yang Zheng, Yi-Hui Zheng, Jia-Hui Wang, Tie-Jian Zhao, Lei Wang, Tian-Jian Liang
The endoplasmic reticulum (ER) is connected to mitochondria through mitochondria-associated ER membranes (MAMs). MAMs provide a framework for crosstalk between the ER and mitochondria, playing a crucial role in regulating cellular calcium balance, lipid metabolism, and cell death. Dysregulation of MAMs is involved in the development of chronic liver disease (CLD). In CLD, changes in MAMs structure and function occur due to factors such as cellular stress, inflammation, and oxidative stress, leading to abnormal interactions between mitochondria and the ER, resulting in liver cell injury, fibrosis, and impaired liver function...
April 27, 2024: World Journal of Hepatology
https://read.qxmd.com/read/38689743/molecular-mechanism-of-nanomaterials-induced-liver-injury-a-review
#11
REVIEW
Sanjib Kumar Das, Koushik Sen, Biswatosh Ghosh, Nabanita Ghosh, Krishnendu Sinha, Parames C Sil
The unique physicochemical properties inherent to nanoscale materials have unveiled numerous potential applications, spanning beyond the pharmaceutical and medical sectors into various consumer industries like food and cosmetics. Consequently, humans encounter nanomaterials through diverse exposure routes, giving rise to potential health considerations. Noteworthy among these materials are silica and specific metallic nanoparticles, extensively utilized in consumer products, which have garnered substantial attention due to their propensity to accumulate and induce adverse effects in the liver...
April 27, 2024: World Journal of Hepatology
https://read.qxmd.com/read/38689742/metabolic-dysfunction-associated-steatotic-liver-disease-a-silent-pandemic
#12
EDITORIAL
Arghya Samanta, Moinak Sen Sarma
The worldwide epidemiology of non-alcoholic fatty liver disease (NAFLD) is showing an upward trend, parallel to the rising trend of metabolic syndrome, owing to lifestyle changes. The pathogenesis of NAFLD has not been fully understood yet. Therefore, NAFLD has emerged as a public health concern in the field of hepatology and metabolisms worldwide. Recent changes in the nomenclature from NAFLD to metabolic dysfunction-associated steatotic liver disease have brought a positive outlook changes in the understanding of the disease process and doctor-patient communication...
April 27, 2024: World Journal of Hepatology
https://read.qxmd.com/read/38689741/erdafitinib-and-checkpoint-inhibitors-for-first-line-and-second-line-immunotherapy-of-hepatic-gastrointestinal-and-urinary-bladder-carcinomas-recent-concept
#13
EDITORIAL
Mohamed Wishahi
Cancer immunotherapy is administered for first-line, second-line, neoadjuvant, or adjuvant treatment of advanced, metastatic, and recurrent cancer in the liver, gastrointestinal tract, and genitourinary tract, and other solid tumors. Erdafitinib is a fibroblast growth factor receptor (FGFR) inhibitor, and it is an adenosine triphosphate competitive inhibitor of FGFR1, FGFR2, FGFR3, and FGFR4. Immune checkpoint inhibitors are monoclonal antibodies that block programmed cell death protein 1 (PD-1) and its ligand that exert intrinsic antitumor mechanisms...
April 27, 2024: World Journal of Hepatology
https://read.qxmd.com/read/38689740/expression-and-clinical-significance-of-short-chain-fatty-acids-in-patients-with-intrahepatic-cholestasis-of-pregnancy
#14
JOURNAL ARTICLE
Shuai-Jun Ren, Jia-Ting Feng, Ting Xiang, Cai-Lian Liao, Yu-Ping Zhou, Rong-Rong Xuan
BACKGROUND: Intrahepatic cholestasis of pregnancy (ICP) is a pregnancy-specific liver condition that typically arises in the middle and late stages of pregnancy. Short-chain fatty acids (SCFAs), prominent metabolites of the gut microbiota, have significant connections with various pregnancy complications, and some SCFAs hold potential for treating such complications. However, the metabolic profile of SCFAs in patients with ICP remains unclear. AIM: To investigate the metabolic profiles and differences in SCFAs present in the maternal and cord blood of patients with ICP and determine the clinical significance of these findings...
April 27, 2024: World Journal of Hepatology
https://read.qxmd.com/read/38683193/an-assessment-of-risk-factors-for-recurrence-and-survival-for-patients-undergoing-liver-resection-for-intrahepatic-cholangiocarcinoma
#15
JOURNAL ARTICLE
Nazli Begüm Öztürk, Laith H Jamil
BACKGROUND AND AIMS: Intrahepatic cholangiocarcinoma (iCCA) is the second most common primary liver malignancy with increasing rates of incidence and mortality. Surgical resection is curative for patients who are diagnosed at early stages of iCCA. Limited data exist regarding risk factors for postresection recurrence and overall survival as iCCA is rare, and majority of patients are diagnosed at an advanced stage and thus not candidates for resection. We aimed to analyze clinical and laboratory characteristics, tumor histology, locoregional invasion, recurrence and survival in patients undergoing curative resection for iCCA...
June 1, 2024: European Journal of Gastroenterology & Hepatology
https://read.qxmd.com/read/38680268/machine-learning-in-liver-surgery-benefits-and-pitfalls
#16
JOURNAL ARTICLE
Rafael Calleja, Manuel Durán, María Dolores Ayllón, Ruben Ciria, Javier Briceño
The application of machine learning (ML) algorithms in various fields of hepatology is an issue of interest. However, we must be cautious with the results. In this letter, based on a published ML prediction model for acute kidney injury after liver surgery, we discuss some limitations of ML models and how they may be addressed in the future. Although the future faces significant challenges, it also holds a great potential.
April 26, 2024: World Journal of Clinical Cases
https://read.qxmd.com/read/38596498/optimizing-nutrition-in-hepatic-cirrhosis-a-comprehensive-assessment-and-care-approach
#17
REVIEW
Osvely Mendez-Guerrero, Anaisa Carranza-Carrasco, Luis Alberto Chi-Cervera, Aldo Torre, Nalu Navarro-Alvarez
Cirrhosis is considered a growing cause of morbidity and mortality, which represents a significant public health problem. Currently, there is no effective treatment to reverse cirrhosis. Treatment primarily centers on addressing the underlying liver condition, monitoring, and managing portal hypertension-related complications, and evaluating the potential for liver transplantation in cases of decompensated cirrhosis, marked by rapid progression and the emergence of complications like variceal bleeding, hepatic encephalopathy, ascites, malnutrition, and more...
March 14, 2024: World Journal of Gastroenterology: WJG
https://read.qxmd.com/read/38584112/-research-progress-on-the-mechanism-of-action-of-heme-oxygenase-1-regulating-ferroptosis-in-non-alcoholic-fatty-liver-disease
#18
JOURNAL ARTICLE
X W Yuan, Y M Nan
Non-alcoholic fatty liver disease (NAFLD) has gradually become the most prevalent chronic liver disease in the world, but its pathogenesis has not been fully elucidated. Ferroptosis is a novel type of programmed cell death caused by iron-dependent lipid peroxidation. Heme oxygenase-1 is a recognized antioxidant enzyme and an important regulatory factor in ferroptosis that modulates ferroptosis through various pathways and, in turn, regulates NAFLD. This paper reviews the regulatory mechanism of heme oxygenase-1 on NAFLD in ferroptosis pathway, with a view to clarifying the occurrence and development mechanisms of NAFLD and providing new vision and targets for its prevention and treatment...
March 20, 2024: Zhonghua Gan Zang Bing za Zhi, Zhonghua Ganzangbing Zazhi, Chinese Journal of Hepatology
https://read.qxmd.com/read/38577541/retrospective-study-of-the-incidence-risk-factors-treatment-outcomes-of-bacterial-infections-at-uncommon-sites-in-cirrhotic-patients
#19
JOURNAL ARTICLE
Sophie Schneitler, Christina Schneider, Markus Casper, Frank Lammert, Marcin Krawczyk, Sören L Becker, Matthias Christian Reichert
BACKGROUND: Bacterial infections (BI) negatively affect the natural course of cirrhosis. The most frequent BI are urinary tract infections (UTI), pneumonia, and spontaneous-bacterial peritonitis (SBP). AIM: To assess the relevance of bacterial infections beyond the commonly recognized types in patients with cirrhosis and to investigate their relationship with other clinical variables. METHODS: We retrospectively analyzed patients with cirrhosis and BI treated between 2015 and 2018 at our tertiary care center...
March 27, 2024: World Journal of Hepatology
https://read.qxmd.com/read/38577540/prognostic-value-of-neutrophil-to-lymphocyte-ratio-in-end-stage-liver-disease-a-meta-analysis
#20
JOURNAL ARTICLE
Xiang-Hao Cai, Yun-Ming Tang, Shu-Ru Chen, Jia-Hui Pang, Yu-Tian Chong, Hong Cao, Xin-Hua Li
BACKGROUND: The neutrophil-to-lymphocyte ratio (NLR) is commonly utilized as a prognostic indicator in end-stage liver disease (ESLD), encompassing conditions like liver failure and decompensated cirrhosis. Nevertheless, some studies have contested the prognostic value of NLR in ESLD. AIM: To investigate the ability of NLR to predict ESLD. METHODS: Databases, such as Embase, PubMed, Web of Science, Cochrane Library, China National Knowledge Infrastructure, Weipu, and Wanfang, were comprehensively searched to identify studies published before October 2022 assessing the prognostic ability of NLR to predict mortality in patients with ESLD...
March 27, 2024: World Journal of Hepatology
keyword
keyword
111114
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.